期刊文献+

非甾体抗炎药的临床应用及不良反应研究进展 被引量:27

Non-steroidal anti-inflammatory drugs (NSAID)-uses, complications and prospect
下载PDF
导出
摘要 非甾体抗炎药 (non steroidalanti inflammatorydurgs,NSAID)在临床上的应用非常广泛 ,用于治疗类风湿性关节炎、骨关节炎及其他风湿性疾病 ,其常见不良反应主要有胃肠道损害、肾脏损害、肝脏以及血液等系统损害。其发生机制与抑制前列腺素合成有关 ,预防或减弱NSAID不良反应的措施是合理用药、避免NSAID滥用、使用胃黏膜保护剂等。今后NSAID发展的方向应是选择性COX 2抑制剂、NO释放型NSAID以及选择性COX 2 / 5 Non steroidal anti inflammatory drugs(NSAID) are among the most widely prescribed medications, primarily for treatment arthritis. Their use is limited by significant toxicity, particularly vin the gastrointestinal tract and kidney. The pathogenesis of NSAID induced gastropathy is related to two main mechanism: an initial topical effect which is PH dependent and a systemic effect which is , more slowly developing and mainly correlated to the inhibition of prostaglandin synthesis. Many new NSAID are not only less toxic but more efficacious, such as selective COX 2 inhibitors, NO releasing NSAIDs and selective COX 2/5 Lox dual inhibitors.
出处 《安徽医药》 CAS 2001年第3期161-163,共3页 Anhui Medical and Pharmaceutical Journal
关键词 非甾体抗炎药 不良反应 NSAID 临床应用 软组织疾病 炎症 NSAID treatment complications COX 2 inhibitors NO releasing NSAID
  • 相关文献

参考文献17

  • 1Sheng H, Shao J, Kirkland SC et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxgenase-2. J Clin Invest, 1997; 99: 2254 被引量:1
  • 2Sandler RS. Aspirin and other non-steroidal anti-inflammatory agents in the prevention of colorectal cancer. Important Adv Oncol,1996:123~37 被引量:1
  • 3Hawkey C, Kahan A, Steinbrack K et al. Gastrointestinal tolerability of meloxicam campared to diclofenac in osteoar4thritis patients. Br J Rheumatol, 1998;37(9) :937~45 被引量:1
  • 4Griffin-MR. Epidemiology of non-steroidal anti-inflammatory drugassociated gastrointestinal injury. Am J Med, 1998;104:23~9 被引量:1
  • 5Griffin MR, Yared A, Ray WA. Non-steroidal anti-inflammatory drug and acute renal failure in elderly persons. Am J Epidemiol,2000; 151(5) :488~96 被引量:1
  • 6Morales JM. Durg-induced hepatotoxicity. N Engl J Med, 1996;334: 864 被引量:1
  • 7Staerkel P, Horsmans Y. Meloxicam-induced liver toxicity. Acta Gastroenterol Belg , 1999;62(2) :255~6 被引量:1
  • 8Seaton RA, Fance AJ. Recurrent aseptic meningitis following nonsteroidal anti-inflammatory drugs-A reminder. Postgrad Med J,1999;75(890) :771~2 被引量:1
  • 9Alarcon GS, Morgan SL. Guidelines for folate supplementation in rheumatoid arthritis patients treat with methotrexate comment on the guidelines for monitoring drug therapy. Arthritis Rheum,1997;40:391 被引量:1
  • 10De Leeeuw PW. Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective. Drugs, 1996;51:179~87 被引量:1

二级参考文献23

  • 1杨君义,宫玉珍.非甾体抗炎药对血小板功能的影响[J].国外医药(合成药.生化药.制剂分册),1996,17(3):160-163. 被引量:6
  • 2黄世杰.默克公司为Rofecoxib提交美国新药申请[J].国外医学:药学分册,1999,26(4):252-253. 被引量:3
  • 3黄世杰.FDA关节炎小组支持批准celecoxib[J].国外医学:药学分册,1999,26(3):191-191. 被引量:4
  • 4LefkowithJB.Cyclooxygenase-2specificityanditsclinicalimplication[J].AmJMed,1999,106(5B)∶43S-49S.[3]大野岩男.NSAIDsによる肾障害[J].医学のぁゆみ,1998,187(11)∶933-936. 被引量:1
  • 5VanJ,BottingJ.SelectiveCOX-2inhibitors:pharmacology,clinicaleffectsandtherapeuticpotential[M].London:Dordrec-ht/Boton,1997.87-98. 被引量:1
  • 6CarrsonJL,WilletL.Toxicityofnonsteroidalantiinflammatorydrugs[J].Drugs,1993,46(Suppl1)∶S243-248. 被引量:1
  • 7RodriguezLAG,JickH.Riskofuppergastrointestinalbleedingandperforrationassociatedwithindividualnonsteroidalantiinflammatorydrugs[J].Lancet,1994,342∶769-772. 被引量:1
  • 8HenryD,LimLYL,RodriguezLAG,etal.Varibilityinriskofgastrointestinalcomplicationswithindividualnonsteroidalantiinflammatorydrugs:resultsofacollaborativemeta-analysis[J].BMJ,1996,312∶1563-1566. 被引量:1
  • 9WallaceJL.Prostaglandins,NSAIDs,andcytoprotection[J].GasteroenterolClinNorthAm,1992,21(3)∶631-638. 被引量:1
  • 10XarierRabasseda.Nimesulide:aelectivecyclooxygenae-2inhibitorantiinflammatorydrug[J].DrugsToday,1996,32(Suppl)D∶S1-S23. 被引量:1

共引文献46

同被引文献229

引证文献27

二级引证文献243

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部